Abstract
Measures to define treatment response, such as no evidence of disease activity (NEDA), are routinely used in multiple sclerosis (MS) clinical practice. Although spinal cord involvement in MS is frequent and strongly correlated with future disability accrual, its magnetic resonance imaging (MRI) monitoring, in the absence of spinal cord symptoms, is not routinely performed. This study aimed to assess the impact of spinal cord imaging and specifically, the impact of missing asymptomatic spinal cord lesions, in the definition of NEDA status in a cohort of MS patients treated with disease-modifying therapies (DMTs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
